Hypertension Clinical Trials in Guangzhou
6 recruitingGuangzhou, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
CirrhosisPortal HypertensionVarices, Esophageal
Chinese University of Hong Kong375 enrolled8 locationsNCT06549673
Recruiting
Not Applicable
Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN
Refractory Hypertension or Drug-intolerant Hypertension
Shenzhen Pulsecare Medical Technology Co., Ltd.204 enrolled1 locationNCT06877221
Recruiting
Phase 3
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd.338 enrolled25 locationsNCT06666855
Recruiting
Nanshan Elderly Cohort Study
SarcopeniaDeathCancer+7 more
Sun Yat-sen University20,000 enrolled2 locationsNCT03569735